Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pei-Suen Tsou

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Rheumatology Reports|December 9, 2019
Epigenetic Control of Scleroderma: Current Knowledge and Future PerspectivesPei-Suen Tsou
Journal of Autoimmunity|May 21, 2017
Unfolding the pathogenesis of scleroderma through genomics and epigenomicsPei-Suen Tsou, Amr H Sawalha
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2020
Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseasesPei-Suen Tsou, Amr H Sawalha
Trends in Molecular Medicine|June 18, 2024
Senescence and tissue fibrosis: opportunities for therapeutic targetingSteven O'Reilly, Pei-Suen Tsou, John Varga
Nature Reviews. Rheumatology|September 4, 2021
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potentialPei-Suen Tsou, John Varga, Steven O'Reilly
Current Opinion in Rheumatology|August 18, 2022
Role of cellular senescence in the pathogenesis of systemic sclerosisPei-Suen Tsou, Bo Shi, John Varga
Current Opinion in Rheumatology|September 8, 2025
Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implicationsRyan Massay, Carleigh Zahn, Pei-Suen Tsou
The Journal of Pharmacology and Experimental Therapeutics|July 26, 2008
Dissociation between superoxide accumulation and nitroglycerin-induced tolerancePei-Suen Tsou, Vamsi Addanki, Ho-Leung Fung
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2019
Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in SclerodermaPei-Suen Tsou, Dinesh Khanna, Amr H Sawalha
Clinical Immunology (Orlando, Fla.)|April 22, 2018
Caffeine inhibits STAT1 signaling and downregulates inflammatory pathways involved in autoimmunityMerve Iris, Pei-Suen Tsou, Amr H Sawalha
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Rheumatology Reports|December 9, 2019
Epigenetic Control of Scleroderma: Current Knowledge and Future PerspectivesPei-Suen Tsou
Journal of Autoimmunity|May 21, 2017
Unfolding the pathogenesis of scleroderma through genomics and epigenomicsPei-Suen Tsou, Amr H Sawalha
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2020
Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseasesPei-Suen Tsou, Amr H Sawalha
Trends in Molecular Medicine|June 18, 2024
Senescence and tissue fibrosis: opportunities for therapeutic targetingSteven O'Reilly, Pei-Suen Tsou, John Varga
Nature Reviews. Rheumatology|September 4, 2021
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potentialPei-Suen Tsou, John Varga, Steven O'Reilly
Current Opinion in Rheumatology|August 18, 2022
Role of cellular senescence in the pathogenesis of systemic sclerosisPei-Suen Tsou, Bo Shi, John Varga
Current Opinion in Rheumatology|September 8, 2025
Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implicationsRyan Massay, Carleigh Zahn, Pei-Suen Tsou
The Journal of Pharmacology and Experimental Therapeutics|July 26, 2008
Dissociation between superoxide accumulation and nitroglycerin-induced tolerancePei-Suen Tsou, Vamsi Addanki, Ho-Leung Fung
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2019
Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in SclerodermaPei-Suen Tsou, Dinesh Khanna, Amr H Sawalha
Clinical Immunology (Orlando, Fla.)|April 22, 2018
Caffeine inhibits STAT1 signaling and downregulates inflammatory pathways involved in autoimmunityMerve Iris, Pei-Suen Tsou, Amr H Sawalha
Pageof 8